The foundation awards the majority of its grants to U.S. 501(c)(3) organizations and other tax-exempt organizations identified by our staff. (Tax status definitions) (Glossary of terms) ...

Dr. Stellah Bosire champions women’s economic empowerment and health equity. Learn how her work is transforming lives in ...

Many of the questions we receive can be answered by information on our web site, where you can: ...

to develop a minimum viable product/approach for tracing commodities produced by small-scale producers, enabling both producers and the private sector to adjust to emerging import/export requirements ...

to support the delivery of curriculum-based professional learning to New York City Public Schools teachers and build the capacity of staff and leaders to sustain professional learning support.

To evaluate different new diagnostic products for high-priority global health pathogens / conditions and work with manufacturers to accelerate the development and introduction through reference lab ...

To test a midwife continuity of care model and its effectiveness on improving maternal and neonatal health outcomes and how it could be cost-effective and scaled ...

To develop an interactive food system scenario model for Kenya that provides a holistic view of the implications of future changes to the food system to optimize equitable access to safe, affordable, ...

To reduce child mortality in Nigeria, Mali and Niger via mass drug administration of Azithromycin (Powder for Oral Suspension) delivered twice yearly to children under five years of age.

To develop education focused AI models and data sets to enable education technologies supporting priority students better able to assess student misconceptions of math problems.

To develop a benchmark for the evaluation of AI-enabled tutoring systems in mathematics to help public school districts supporting priority students access better solutions and to help product ...

to use artificial intelligence to enhance the yields in the synthesis of intermediates for the TB drugs pretomanid and/or sutezolid which will enable lower cost manufacturing and increased access in ...